Celltrion fine shows tax authority’s ambition to tackle violation of TP standards
The South Korean Financial Services Commission’s KRW 15.4 billion ($12.6 million) fine to global pharmaceutical company Celltrion is a warning to others to comply with accounting standards and transfer pricing rules.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: